Brown Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-2,580,875
| Closed | -$16.8M | – | 134 |
|
2024
Q2 | $16.8M | Sell |
2,580,875
-119,830
| -4% | -$781K | 0.34% | 45 |
|
2024
Q1 | $23.5M | Sell |
2,700,705
-1,008,726
| -27% | -$8.79M | 0.42% | 43 |
|
2023
Q4 | $42.4M | Sell |
3,709,431
-10,365
| -0.3% | -$119K | 0.64% | 35 |
|
2023
Q3 | $35.8M | Sell |
3,719,796
-31,802
| -0.8% | -$306K | 0.55% | 36 |
|
2023
Q2 | $39.9M | Sell |
3,751,598
-182,335
| -5% | -$1.94M | 0.57% | 35 |
|
2023
Q1 | $41.4M | Sell |
3,933,933
-63,112
| -2% | -$664K | 0.62% | 36 |
|
2022
Q4 | $49.5M | Sell |
3,997,045
-4,640,073
| -54% | -$57.5M | 0.82% | 34 |
|
2022
Q3 | $89.5M | Sell |
8,637,118
-3,004,817
| -26% | -$31.1M | 1.25% | 28 |
|
2022
Q2 | $134M | Sell |
11,641,935
-2,587,064
| -18% | -$29.8M | 1.8% | 24 |
|
2022
Q1 | $179M | Sell |
14,228,999
-2,028,900
| -12% | -$25.5M | 1.78% | 23 |
|
2021
Q4 | $190M | Sell |
16,257,899
-746,496
| -4% | -$8.7M | 1.57% | 22 |
|
2021
Q3 | $222M | Sell |
17,004,395
-1,480,364
| -8% | -$19.3M | 1.82% | 20 |
|
2021
Q2 | $238M | Sell |
18,484,759
-1,685,367
| -8% | -$21.7M | 1.8% | 24 |
|
2021
Q1 | $226M | Buy |
20,170,126
+19,663
| +0.1% | +$220K | 1.68% | 25 |
|
2020
Q4 | $230M | Buy |
20,150,463
+47,171
| +0.2% | +$537K | 1.59% | 24 |
|
2020
Q3 | $181M | Buy |
20,103,292
+1,305,231
| +7% | +$11.7M | 1.5% | 24 |
|
2020
Q2 | $194M | Buy |
18,798,061
+837,212
| +5% | +$8.64M | 1.67% | 23 |
|
2020
Q1 | $181M | Buy |
17,960,849
+59,796
| +0.3% | +$603K | 2.1% | 24 |
|
2019
Q4 | $238M | Sell |
17,901,053
-29,728
| -0.2% | -$396K | 2.28% | 23 |
|
2019
Q3 | $154M | Buy |
17,930,781
+5,600,891
| +45% | +$48.1M | 1.49% | 26 |
|
2019
Q2 | $135M | Sell |
12,329,890
-116
| -0% | -$1.27K | 1.28% | 29 |
|
2019
Q1 | $140M | Buy |
12,330,006
+235,585
| +2% | +$2.67M | 1.41% | 29 |
|
2018
Q4 | $105M | Buy |
12,094,421
+4,393,705
| +57% | +$38.1M | 1.26% | 29 |
|
2018
Q3 | $119M | Buy |
7,700,716
+172,002
| +2% | +$2.66M | 1.08% | 27 |
|
2018
Q2 | $121M | Buy |
7,528,714
+48,513
| +0.6% | +$777K | 1.24% | 25 |
|
2018
Q1 | $96.7M | Buy |
7,480,201
+1,194
| +0% | +$15.4K | 1.1% | 26 |
|
2017
Q4 | $93.9M | Buy |
7,479,007
+55,222
| +0.7% | +$693K | 1.14% | 27 |
|
2017
Q3 | $98.1M | Buy |
7,423,785
+1,793
| +0% | +$23.7K | 1.19% | 27 |
|
2017
Q2 | $117M | Buy |
7,421,992
+1,343,250
| +22% | +$21.2M | 1.44% | 26 |
|
2017
Q1 | $86.9M | Buy |
+6,078,742
| New | +$86.9M | 1.16% | 28 |
|